PRP19 Antibodies

Santa Cruz Biotechnology delivers a wide array of PRP19 monoclonal antibodies for research focused on understanding PRP19 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRP19, also known as P53R2, is a crucial component of the spliceosome and plays a significant role in pre-mRNA splicing and DNA damage response. PRP19's involvement in cellular processes is essential for maintaining cellular homeostasis and regulating gene expression. Research has shown that PRP19 alterations can contribute to various diseases, including cancer, highlighting its significance as a potential therapeutic target. Understanding PRP19's molecular mechanisms and cellular functions continues to be an active area of investigation in molecular biology and disease research. Exploring PRP19's role in cellular signaling pathways provides valuable insights into disease development and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PRP19's role in health and disease.